CD8A and melanoma: The total number of CD8+ T cells in tumor-involved SLNs appears to decrease vs. tumor-free nodes, and CD8+ T cells within the melanoma-involved SLN demonstrated increased expression of exhaustion markers, including programmed death ligand-1 (PD-L1) [11,12].